The Lifetime Cost Estimation of Human Papillomavirus-related Diseases in China: A Modeling Study.

ABSTRACT:

Objectives

To estimate the lifetime treatment costs of patients with human papillomavirus (HPV) infection-related diseases in China and to provide cost estimates for the economic evaluation of HPV intervention strategies.

Methods

We extracted real-world hospital data from 2012 to 2019 and screened for subjects who met the criteria of clinical diagnosis of HPV-related diseases to obtain country-specific inputs into a Markov decision model. The model simulated lifetime treatment costs for HPV from the perspective of a national payer. A 5% discount rate was applied. Costs were converted and inflated to 2020 US dollars (USD).

Results

Using 2021 as the base year, the lifetime costs per patient for carcinoma in situ, local metastasis, and distant metastasis cervical cancer

SUBMITTER: Ding W 

PROVIDER: S-EPMC8629412 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature